H-Index & Metrics Best Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Medicine D-index 145 Citations 100,984 570 World Ranking 521 National Ranking 59

Research.com Recognitions

Awards & Achievements

1999 - Fellow of the Royal Society of Edinburgh

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Statistics
  • Myocardial infarction

Ian Ford mainly investigates Internal medicine, Cardiology, Heart failure, Myocardial infarction and Surgery. His Internal medicine study combines topics from a wide range of disciplines, such as Diabetes mellitus and Endocrinology. The study incorporates disciplines such as Ivabradine and Heart rate in addition to Cardiology.

His Heart failure study deals with Heart disease intersecting with Atrial natriuretic peptide and Brain natriuretic peptide. His research investigates the link between Myocardial infarction and topics such as Prospective cohort study that cross with problems in Mendelian Randomization Analysis. His Surgery research is multidisciplinary, incorporating perspectives in Framingham Risk Score, Disease, Fibrinogen, Pravastatin and Risk factor.

His most cited work include:

  • Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia (6962 citations)
  • Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial (2750 citations)
  • Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials (1677 citations)

What are the main themes of his work throughout his whole career to date?

Internal medicine, Cardiology, Heart failure, Myocardial infarction and Randomized controlled trial are his primary areas of study. His work focuses on many connections between Internal medicine and other disciplines, such as Surgery, that overlap with his field of interest in Risk factor. Ian Ford combines subjects such as Placebo and Ivabradine, Heart rate with his study of Cardiology.

His work deals with themes such as Clinical endpoint and Intensive care medicine, which intersect with Heart failure. His Myocardial infarction research includes elements of Diabetes mellitus, Disease and Blood pressure. The concepts of his Randomized controlled trial study are interwoven with issues in Physical therapy and Clinical trial.

He most often published in these fields:

  • Internal medicine (62.56%)
  • Cardiology (35.96%)
  • Heart failure (20.32%)

What were the highlights of his more recent work (between 2017-2021)?

  • Internal medicine (62.56%)
  • Cardiology (35.96%)
  • Myocardial infarction (20.81%)

In recent papers he was focusing on the following fields of study:

Ian Ford mainly focuses on Internal medicine, Cardiology, Myocardial infarction, Stroke and Heart failure. In his study, which falls under the umbrella issue of Internal medicine, Meta-analysis is strongly linked to Placebo. His work on Conventional PCI as part of his general Cardiology study is frequently connected to In patient, thereby bridging the divide between different branches of science.

His studies examine the connections between Stroke and genetics, as well as such issues in Angina, with regards to Renal function. The various areas that he examines in his Heart failure study include Diabetes mellitus, Anesthesia and Proportional hazards model. His Hazard ratio research focuses on Prospective cohort study and how it relates to Pravastatin and Risk factor.

Between 2017 and 2021, his most popular works were:

  • Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps. (503 citations)
  • MRI-Guided Thrombolysis for Stroke with Unknown Time of Onset (411 citations)
  • Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies (385 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Statistics
  • Disease

The scientist’s investigation covers issues in Internal medicine, Genome-wide association study, Randomized controlled trial, Cardiology and Heart failure. His research in Myocardial infarction, Stroke, Coronary artery disease, Odds ratio and Hazard ratio are components of Internal medicine. His Genome-wide association study research incorporates elements of Minor allele frequency, Genetic association and Medical genetics.

His biological study spans a wide range of topics, including Weight loss, Percutaneous coronary intervention, Adverse effect, Placebo and Type 2 diabetes. His work carried out in the field of Cardiology brings together such families of science as Plasma renin activity, Aldosterone, Blood pressure and Confidence interval. His studies deal with areas such as Anesthesia, Ivabradine and Mendelian inheritance as well as Heart failure.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia

Shepherd J;Cobbe Sm;Ford I;Isles Cg.
The New England Journal of Medicine (1995)

10600 Citations

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

James Shepherd;Gerard J Blauw;Michael B Murphy;Edward Lem Bollen.
The Lancet (2002)

4225 Citations

Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials

Naveed Sattar;David Preiss;Heather M Murray;Paul Welsh.
The Lancet (2010)

2721 Citations

Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study.

Karl Swedberg;Michel Komajda;Michael Böhm;Jeffrey S Borer.
The Lancet (2010)

2659 Citations

Metabolic Syndrome With and Without C-Reactive Protein as a Predictor of Coronary Heart Disease and Diabetes in the West of Scotland Coronary Prevention Study

Naveed Sattar;Allan Gaw;Olga Scherbakova;Ian Ford.
Circulation (2003)

1993 Citations

Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy

Christian Templin;Jelena R. Ghadri;Johanna Diekmann;L. Christian Napp.
The New England Journal of Medicine (2015)

1515 Citations

Defining the role of common variation in the genomic and biological architecture of adult human height

Andrew R. Wood;Tonu Esko;Jian Yang;Sailaja Vedantam.
Nature Genetics (2014)

1508 Citations

Biochemical detection of left-ventricular systolic dysfunction

TA McDonagh;SD Robb;Murdoch;JJ Morton.
The Lancet (1998)

1444 Citations

Diffuse axonal injury in head injury: definition, diagnosis and grading.

J H Adams;D Doyle;I Ford;T A Gennarelli.
Histopathology (1989)

1423 Citations

2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA).

Steen Dalby Kristensen;Juhani Knuuti;Antti Saraste;Stefan Anker.
European Heart Journal (2014)

1384 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Ian Ford

Naveed Sattar

Naveed Sattar

University of Glasgow

Publications: 304

George Davey Smith

George Davey Smith

University of Bristol

Publications: 256

Ian J. Deary

Ian J. Deary

University of Edinburgh

Publications: 248

Paul M. Ridker

Paul M. Ridker

Harvard Medical School

Publications: 245

Bruce M. Psaty

Bruce M. Psaty

University of Washington

Publications: 220

Andrew M. McIntosh

Andrew M. McIntosh

University of Edinburgh

Publications: 219

Mark I. McCarthy

Mark I. McCarthy

University of Oxford

Publications: 219

David J. Porteous

David J. Porteous

University of Edinburgh

Publications: 212

Albert Hofman

Albert Hofman

Harvard University

Publications: 211

Caroline Hayward

Caroline Hayward

University of Edinburgh

Publications: 205

John J.V. McMurray

John J.V. McMurray

University of Glasgow

Publications: 201

Erik Ingelsson

Erik Ingelsson

Stanford University

Publications: 184

Olli T. Raitakari

Olli T. Raitakari

Turku University Hospital

Publications: 184

André G. Uitterlinden

André G. Uitterlinden

Erasmus University Rotterdam

Publications: 181

Nilesh J. Samani

Nilesh J. Samani

University of Leicester

Publications: 180

John G.F. Cleland

John G.F. Cleland

National Institutes of Health

Publications: 179

Something went wrong. Please try again later.